Andrographis paniculata Report issue

Botanical Experimental
AACT DrugBank PubChem

Active Ingredient History

NOW
  • Now
Andrographolide is a labdane diterpenoid that has been isolated from the stem and leaves of Andrographis paniculata. Andrographolide is an extremely bitter substance.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

andrographis | andrographis paniculata extract | andrographolide | andrographolide sulfonate | hmpl004 | hmpl-004

Organizations (35)

Research & Development (35)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (14)

Approved Indications (1)


 

Dietary Supplements

Experimental Indications - Clinical Trial Phases 1-4 (13)


 

Bronchitis (Phase 4)

Colitis, Ulcerative (Phase 3)

Colorectal Neoplasms (Phase 2)

Community-Acquired Infections (Phase 4)

COVID-19 (Phase 3)

Crohn Disease (Phase 2)

Esophageal Neoplasms (Phase 3)

Molecular Mechanisms of Pharmacological Action (Phase 1)

Multiple Sclerosis, Chronic Progressive (Phase 1/Phase 2)

Multiple Sclerosis, Relapsing-Remitting (Phase 1/Phase 2)

Pharmacokinetics (Phase 1)

Respiratory Tract Infections (Phase 3)

Tonsillitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 20
  • # of Trial Organizations: 35

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue